AUCTA PHARMACEUTICALS

Serial Number 90800831
748

Registration Progress

Application Filed
Jun 29, 2021
Under Examination
Dec 27, 2022
Approved for Publication
Nov 1, 2022
Published for Opposition
Nov 1, 2022
Registered

Trademark Image

AUCTA PHARMACEUTICALS

Basic Information

Serial Number
90800831
Filing Date
June 29, 2021
Published for Opposition
November 1, 2022
Drawing Code
3

Status Summary

Current Status
Active
Status Code
748
Status Date
Dec 29, 2025
Application
Pending
Classes
005

Rights Holder

Aucta Pharmaceuticals, Inc.

03
Address
71 Suttons Lane
Piscataway, NJ 08854

Ownership History

Aucta Pharmaceuticals, Inc.

Original Applicant
03
Piscataway, NJ

Aucta Pharmaceuticals, Inc.

Owner at Publication
03
Piscataway, NJ

Legal Representation

Attorney
Michael J, Leonard

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

39 events
Date Code Type Description Documents
Dec 29, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 23, 2025 IUAF S USE AMENDMENT FILED Loading...
Dec 23, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 6, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 5, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 4, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 4, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 5, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 5, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 5, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 4, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 27, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 27, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 27, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 27, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 21, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 19, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 19, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 19, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 29, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 27, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 27, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 27, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 27, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 1, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 1, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 12, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 26, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 21, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 21, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 21, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 22, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 22, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 22, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 21, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 11, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 10, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 2, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in the treatment of seizures, bipolar disorders, depression and neurofibromatosis; Pharmaceutical preparations for the prevention and treatment of central nervous system disorders, neurological diseases and disorders, neurodegenerative disorders, and depression
First Use Anywhere: Feb 16, 2024
First Use in Commerce: Feb 16, 2024

Additional Information

Design Mark
The mark consists of an image of a triangle inside a square located to the left of the wording "AUCTA" stacked above the term "PHARMACEUTICALS".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"